Home
About
Overview
Sharing Data
ORCID
Help
History (34)
Infective gangrene in extremity trauma-are we targeting the right organisms?
Eyes on the Prize: Decoding the Ophthalmic Product Regulations and Intricacies of the U.S. Food and Drug Administration Approval.
The current status of the use of palonosetron.
Computerized assessment of motion-contaminated calcified plaques in cardiac multidetector CT.
Response to Drs. Simpson, et al.: Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group clinical trials.
See All 34 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Sand, Peter
One or more keywords matched the following items that are connected to
Sand, Peter
Item Type
Name
Concept
Double-Blind Method
Academic Article
Prospective randomized controlled trial of extended-release oxybutynin chloride and tolterodine tartrate in the treatment of overactive bladder: results of the OBJECT Study.
Academic Article
Comparative efficacy and safety of transdermal oxybutynin and oral tolterodine versus placebo in previously treated patients with urge and mixed urinary incontinence.
Academic Article
Extended-release formulations of oxybutynin and tolterodine exhibit similar central nervous system tolerability profiles: a subanalysis of data from the OPERA trial.
Academic Article
The effect of preemptive pudendal nerve blockade on pain after transvaginal pelvic reconstructive surgery.
Academic Article
A comparison of extended-release oxybutynin and tolterodine for treatment of overactive bladder in women.
Academic Article
Time to initiation of pentosan polysulfate sodium treatment after interstitial cystitis diagnosis: effect on symptom improvement.
Academic Article
Efficacy and safety of oxybutynin chloride topical gel for overactive bladder: a randomized, double-blind, placebo controlled, multicenter study.
Academic Article
Trospium chloride once-daily extended release is effective and well tolerated for the treatment of overactive bladder syndrome: an integrated analysis of two randomised, phase III trials.
Academic Article
Safety and tolerability of extended-release oxybutynin once daily in urinary incontinence: combined results from two phase 4 controlled clinical trials.
Academic Article
Efficacy, safety and tolerability of fesoterodine for overactive bladder syndrome.
Academic Article
Association between response to pentosan polysulfate sodium therapy for interstitial cystitis and patient questionnaire-based treatment satisfaction.
Academic Article
Trospium 60 mg once daily (QD) for overactive bladder syndrome: results from a placebo-controlled interventional study.
Academic Article
Pelvic floor electrical stimulation in the treatment of genuine stress incontinence: a multicenter, placebo-controlled trial.
Academic Article
Long-term safety, tolerability, and efficacy of fesoterodine treatment in men and women with overactive bladder symptoms.
Academic Article
Once-daily trospium chloride 60 mg extended-release provides effective, long-term relief of overactive bladder syndrome symptoms.
Academic Article
Efficacy and safety of oxybutynin chloride topical gel for women with overactive bladder syndrome.
Academic Article
Treatment satisfaction and goal attainment with onabotulinumtoxinA in patients with incontinence due to idiopathic OAB.
Academic Article
Once daily trospium chloride is effective and well tolerated for the treatment of overactive bladder: results from a multicenter phase III trial.
Academic Article
Trospium chloride extended release is effective and well tolerated in women with overactive bladder syndrome.
Academic Article
Once-daily trospium chloride 60 mg extended release in subjects with overactive bladder syndrome who use multiple concomitant medications: Post hoc analysis of pooled data from two randomized, placebo-controlled trials.
Academic Article
Prospective, randomized, double-blind study of the efficacy and tolerability of the extended-release formulations of oxybutynin and tolterodine for overactive bladder: results of the OPERA trial.
Academic Article
Efficacy and tolerability of fesoterodine in women with overactive bladder.
Academic Article
Efficacy and safety of low dose desmopressin orally disintegrating tablet in women with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study.
Academic Article
Efficacy and safety of oxybutynin topical gel 3% in patients with urgency and/or mixed urinary incontinence: a randomized, double-blind, placebo-controlled study.
Search Criteria
Double Blind Method